6 March 2026 in Liver International
Background and Aims: Intrahepatic metastasis negatively impacts the prognosis of several cancers, including hepatocellular and colorectal carcinoma. Zebrafish larval xenografts serve as a robust vertebrate platform that allows direct visualisation of tumour behaviour within a living organism. However, organ‐specific metastasis models in zebrafish remain limited, and liver metastasis has not yet been demonstrated. This study aimed to establish a zebrafish larval intrahepatic metastasis model and to determine the role of c‐Met activation in mediating liver tropism of cancer cells. Methods: An intravenous injection–based zebrafish model (zLiverMet) was developed using a liver‐specific fluorescent reporter line to visualise tumour colonisation in vivo. Liver cancer cell lines with distinct c‐Met expression and activation levels were injected into 2‐day post‐fertilisation larvae. The effects of c‐Met overexpression and pharmacological inhibition on intrahepatic metastasis were analysed through confocal imaging and quantitative image measurements. The model's applicability was further tested using colorectal cancer (CRC) cell lines. Results: Intravenous injection facilitated efficient intrahepatic colonisation, whereas yolk‐sac injection failed to reproduce vascular dissemination. Liver cancer cell lines with high c‐Met expression, SNU‐449, Mahlavu and SK‐HEP‐1, exhibited strong liver tropism, while cell lines with no/low c‐Met expression, HuH‐7 and SNU‐398, showed minimal hepatic metastasis. Overexpressing c‐Met increased liver colonisation of HCC cells, and inhibiting c‐Met activation with the c‐Met inhibitor SU11274 reduced this effect. Conclusions: The zLiverMet model successfully mimics intrahepatic metastasis and highlights c‐Met as a driver of liver tropism. This zebrafish‐based model offers an ‘organism‐on‐a‐chip’ platform that is rapid, imageable and scalable—bridging in vitro assays and in vivo models for mechanistic and therapeutic studies of liver metastasis.
25 January 2024 in bioRxiv
Macular corneal dystrophy (MCD) is a rare congenital disease caused by mutations in the carbohydrate sulfotransferase 6 ( chst6 ) gene. Patients suffer from opaque aggregates in the cornea leading to bilateral progressive vision loss by 4 th decade of life. Corneal transplantation is the only available treatment, which is invasive, not available to every patient and recurrence of the symptoms is common. Keratocytes in the cornea express the chst6 gene, which encodes a golgi enzyme that is essential for sulfation of the keratan sulfate proteoglycans (KSPG). The loss of KS sulfation leads to defects in collagen fibril organization and aggregate formation in the corneal extracellular matrix. Lack of preclinical disease models is a major limitation for the development of accessible treatment strategies. Attempts to develop mouse MCD models have failed due to lack of chst6 gene in mice and difference in proteoglycan composition of the mouse cornea. The zebrafish chst6 gene has not been studied previously. Zebrafish cornea structure is highly similar to humans, containing high levels of keratan sulfate proteoglycans in the stroma. Here, loss of function chst6 mutant zebrafish were generated with CRISPR/Cas9 mediated gene editing. Several chst6 alleles were obtained, and loss of KSPG sulfation in the eye stroma was shown. Mutant zebrafish developed age-dependent, alcian blue positive, opaque accumulates in the cornea. Degeneration of corneal structure and changes in epithelial thickness were observed. The zebrafish MCD model developed here is the first in vivo model of the disease and opens up possibilities to develop and screen treatment strategies. Significance Statement: First in vivo model of macular corneal dystrophy (MCD) is reported in this study. Zebrafish model developed here paves the way for modeling of other corneal dystrophies in this aquatic vertebrate which is easy to apply therapeutics and image in vivo . The clinical symptoms of MCD are well reproduced in the zebrafish MCD model. Moreover, the authors showed that chst6 gene function is not restricted to cornea, and a fraction of mutant larvae have morphological defects. The mutants developed here provide a genetic model for understanding the highly complex roles of keratan sulfate proteoglycans.